Today: 11 June 2026
Browse Category

NASDAQ:HTH 30 January 2026

Hilltop Holdings (HTH) stock climbs after dividend hike, new $125 mln buyback and Q4 profit lift

Hilltop Holdings (HTH) stock climbs after dividend hike, new $125 mln buyback and Q4 profit lift

Hilltop Holdings shares rose 2.9% to $37.87 Friday after the company reported a Q4 profit of $41.6 million and raised its quarterly dividend to $0.20 per share. The board approved a new $125 million stock buyback plan through January 2027. Mortgage originations reached $2.4 billion for the quarter. The bank set aside $7.8 million for credit losses as non-accrual loans declined.

Stock Market Today

  • AI Predicts 2026 World Cup Winner: An Unprecedented Underdog
    June 11, 2026, 5:52 PM EDT. AI models forecasting the 2026 World Cup winner are deviating from established patterns by selecting underdogs rarely deemed favorites. This shift highlights the evolving analytical approaches using artificial intelligence in sports predictions, potentially signaling a new era where data-driven insights challenge traditional expert opinions. The 2026 tournament, hosted by North America, could witness a breakthrough as AI underscores the unpredictable nature of football outcomes.

Latest articles

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

Bradesco Shares Rise, BBDC4 and BBD ADRs Track Brazil Market Recovery

11 June 2026
Bradesco’s preferred shares jumped to R$17.67 and U.S. ADRs to $3.44 with heavy volume as Brazil’s Ibovespa surged 1.71%, spotlighting the lender after reporting a 16.1% year-over-year rise in recurring net income to R$6.811 billion in 1Q26; board and executive insiders sold non-voting shares, while the controlling group’s stake remained unchanged.
Bank of Nova Scotia Hits 52-Week High; TSX Bounces Back

Bank of Nova Scotia Hits 52-Week High; TSX Bounces Back

11 June 2026
Bank of Nova Scotia surged to a 52-week high, closing up 1.24% at C$115.27 in Toronto after announcing expanded AI adoption across its workforce and higher Q2 earnings, while the S&P/TSX Composite jumped 1.5% as financials rallied and trading volume soared above average.
Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus

11 June 2026
Moderna surged 7.94% to $49.64 as U.S. stocks rebounded sharply, with investors eyeing its mRNA cancer-vaccine pipeline after a UK trial authorization; Wall Street’s average analyst rating remains “Hold” with a $43.30 target, and BofA raised its price target to $34 citing norovirus prospects, while Moderna reported Q1 revenue of $389 million and a $1.3 billion net loss.
Go toTop